首页> 外文期刊>Nature Communications >Loss of PBRM1 rescues VHL dependent replication stress to promote renal carcinogenesis
【24h】

Loss of PBRM1 rescues VHL dependent replication stress to promote renal carcinogenesis

机译:PBRM1的丢失可挽救VHL依赖的复制应激,从而促进肾脏癌变

获取原文
       

摘要

Inactivation of the VHL (Von Hippel Lindau) tumour suppressor has long been recognised as necessary for the pathogenesis of clear cell renal cancer (ccRCC); however, the molecular mechanisms underlying transformation and the requirement for additional genetic hits remain unclear. Here, we show that loss of VHL alone results in DNA replication stress and damage accumulation, effects that constrain cellular growth and transformation. By contrast, concomitant loss of the chromatin remodelling factor PBRM1 (mutated in 40% of ccRCC) rescues VHL-induced replication stress, maintaining cellular fitness and allowing proliferation. In line with these data we demonstrate that combined deletion of Vhl and Pbrm1 in the mouse kidney is sufficient for the development of fully-penetrant, multifocal carcinomas, closely mimicking human ccRCC. Our results illustrate how VHL and PBRM1 co-operate to drive renal transformation and uncover replication stress as an underlying vulnerability of all VHL mutated renal cancers that could be therapeutically exploited.
机译:长期以来,人们一直认为灭活VHL(Von Hippel Lindau)抑癌剂是透明细胞肾癌(ccRCC)发病机制所必需的;然而,转化的分子机制以及对其他基因突变的需求尚不清楚。在这里,我们显示仅VHL的损失会导致DNA复制压​​力和损伤积累,这种作用会限制细胞的生长和转化。相比之下,染色质重塑因子PBRM1的伴随损失(突变为ccRCC的40%)可以挽救VHL诱导的复制压力,维持细胞健康并允许增殖。根据这些数据,我们证明小鼠肾脏中Vhl和Pbrm1的联合缺失足以发展为完全模仿人ccRCC的全穿透性多灶癌。我们的结果说明了VHL和PBRM1如何协同作用来驱动肾脏转化并揭示复制应激,这是所有可以治疗性利用VHL突变的肾癌的潜在脆弱性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号